Clinical trial
Treatment of Subarachnoid Hemorrhage With Human Albumin
NCT00283400 · Baylor College of Medicine, Other · Terminated
Key facts
| NCT number | NCT00283400 |
|---|---|
| Title | Treatment of Subarachnoid Hemorrhage With Human Albumin |
| Official title | Treatment of Subarachnoid Hemorrhage With Human Albumin |
| Lead sponsor | Baylor College of Medicine, Other |
| Collaborators | National Institute of Neurological Disorders and Stroke (NINDS) NIH |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Subarachnoid Hemorrhage |
| Intervention type | Drug |
| Interventions | 25% human albumin |
| Enrollment | 47 |
| Start date | Jan 1, 2006 |
| Primary completion | Jan 1, 2011 |
| Completion | Apr 1, 2011 |
| First posted | Jan 27, 2006 |
| Last update posted | Apr 1, 2015 |
| Countries | Canada, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: